|
|
Latest Headlines
Xcelience and IriSys business alliance agreement strengthens regional access to CMC/Regulatory expertise
More...
| Xcelience Adds Piccola B10 Minipress for GMP Tablet Formulation Development in Experimental Area
More...
| Xcelience and Penn Pharma Form a Joint Venture to Provide API Into Capsule Services in Europe and Asia Pacific Markets
More...
|
|
|
|
|
|
|
News
|
|
|
|
Xcelience Announced As Finalist for 2009 Small Business of the Year; Recognized for Sustainable Business Growth
|
|
Tampa, FL (August 13, 2009) – Xcelience, a leader in early drug development services is proud to announce our status as finalist for the 2009 Small Business of the Year Award.
|
|
“It is an honor and a privilege to be recognized by the Greater Tampa Chamber of Commerce in this way,” says CEO Derek Hennecke. “Xcelience was founded with the vision that we would stand out from the rest. We believed that with hard work, a quality-first focus, solid financial management, drug development expertise, and continued commitment to going the extra mile for our clients, that we could build a strong, sustainable business. We are pleased that the rigor of this award application process has provided external validation for our efforts.”
|
|
“As dedicated members of the Tampa community, we are extremely proud that client confidence in Xcelience has enabled us to proceed with our expansion strategies, which include job creation” says VP Randall Guthrie. “This marks the second year in a row that Xcelience has been recognized as one of the top companies in the Tampa area. We are honored by the continued recognition for sustainable business growth. “
|
|
Winners for the 29th Annual Small Business of the Year Award will be announced on September 25th at a gala event attended with more than 1,000 attendees.
|
|
Xcelience LLC, is a contract research organization which has been providing formulation development, preformulation, analytical, and clinical trial manufacturing since 1997. The company has a solid reputation for accelerating early development activities to speed potential drugs to clinical trials while applying stage-specific scientific knowledge and experience. Xcelience's unique corporate structure creates project teams that work intensively with each client, bringing an extension of their own organization into the Xcelience lab.
|
|
About Xcelience: Keep on top of new developments in Xcelience and throughout the drug development industry by following us on Twitter www.twitter.com/Xcelience. For more detailed information about Xcelience, visit www.xcelience.com.
|
|
|
|
|
|
|
|
|
|
|
|
|